Published in J Clin Microbiol on September 01, 1983
Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol (1990) 9.53
Improved detection times for Mycobacterium avium complex and Mycobacterium tuberculosis with the BACTEC radiometric system. J Clin Microbiol (1985) 4.58
Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria. J Clin Microbiol (1992) 4.55
Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J Clin Microbiol (1990) 4.31
Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (2002) 4.10
Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol (1999) 4.10
Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods. J Clin Microbiol (1988) 4.02
Whole chromosomal DNA probes for rapid identification of Mycobacterium tuberculosis and Mycobacterium avium complex. J Clin Microbiol (1987) 3.70
Role of solid media when used in conjunction with the BACTEC system for mycobacterial isolation and identification. J Clin Microbiol (1991) 3.60
Evaluation of the MB/BacT system and comparison to the BACTEC 460 system and solid media for isolation of mycobacteria from clinical specimens. J Clin Microbiol (1997) 3.10
Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2002) 3.06
Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth. J Clin Microbiol (1986) 2.87
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol (1985) 2.68
Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. J Clin Microbiol (2002) 2.62
Mycobacterial cross contamination during radiometric culturing. J Clin Microbiol (1988) 2.56
Cord formation in BACTEC 7H12 medium for rapid, presumptive identification of Mycobacterium tuberculosis complex. J Clin Microbiol (1990) 2.55
PCR assay based on DNA coding for 16S rRNA for detection and identification of mycobacteria in clinical samples. J Clin Microbiol (1995) 2.51
Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone. J Clin Microbiol (1984) 2.39
Laboratory diagnosis of mycobacterial infections in patients with acquired immunodeficiency syndrome. J Clin Microbiol (1986) 2.39
Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media. J Clin Microbiol (1999) 2.26
Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates. J Clin Microbiol (1993) 2.25
In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. Antimicrob Agents Chemother (1989) 2.22
Comparison of the MB/BacT and BACTEC 460 TB systems for recovery of mycobacteria from various clinical specimens. J Clin Microbiol (1999) 2.09
Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methods. Antimicrob Agents Chemother (1985) 2.07
Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol (2006) 2.06
Reliability of cord formation in BACTEC media for presumptive identification of mycobacteria. J Clin Microbiol (1993) 1.94
Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother (2003) 1.93
Evaluation of the BACTEC radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol (1985) 1.85
Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85
Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol (1998) 1.85
Comparison of fluorescent BACTEC 9000 MB system, Septi-Chek AFB system, and Lowenstein-Jensen medium for detection of mycobacteria. J Clin Microbiol (1996) 1.79
Rapid susceptibility testing of Mycobacterium tuberculosis by bioluminescence assay of mycobacterial ATP. Antimicrob Agents Chemother (1988) 1.76
Leprosy. Clin Microbiol Rev (1988) 1.74
Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth. J Clin Microbiol (1985) 1.71
The multidrug-resistant tuberculosis challenge to public health efforts to control tuberculosis. Public Health Rep (1993) 1.70
Reliability of the MB/BacT system for testing susceptibility of Mycobacterium tuberculosis complex isolates to antituberculous drugs. J Clin Microbiol (2000) 1.62
Comparison of recovery rates for mycobacteria from BACTEC 12B vials, Middlebrook 7H11-selective 7H11 biplates, and Lowenstein Jensen slants in a public health mycobacteriology laboratory. J Clin Microbiol (1995) 1.58
Evaluation of the LiPA MYCOBACTERIA assay for identification of mycobacterial species from BACTEC 12B bottles. J Clin Microbiol (2000) 1.57
Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods. Antimicrob Agents Chemother (1985) 1.55
Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States. J Clin Microbiol (2001) 1.46
High-throughput screen for detecting antimycobacterial agents. Antimicrob Agents Chemother (1995) 1.46
Multicenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2004) 1.44
Evaluation of the p-nitro-alpha-acetylamino-beta-hydroxypropiophenone differential test for identification of Mycobacterium tuberculosis complex. J Clin Microbiol (1985) 1.43
Evaluation of streptomycin and ethambutol concentrations for susceptibility testing of Mycobacterium tuberculosis by radiometric and conventional procedures. J Clin Microbiol (1986) 1.38
Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2007) 1.32
Effect of PANTA on growth of Mycobacterium kansasii in BACTEC 12B medium. J Clin Microbiol (1995) 1.31
Rapid colorimetric method for testing susceptibility of Mycobacterium tuberculosis to isoniazid and rifampin in liquid cultures. J Clin Microbiol (2003) 1.31
Evaluation of BACTEC MGIT 960 and BACTEC 460TB systems for recovery of mycobacteria from clinical specimens of a university hospital with low incidence of tuberculosis. J Clin Microbiol (2001) 1.27
Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan. J Clin Microbiol (2008) 1.26
Detection of rifampin-resistant Mycobacterium tuberculosis in sputa by nested PCR-linked single-strand conformation polymorphism and DNA sequencing. J Clin Microbiol (2001) 1.25
Evaluation of reverse transcription-PCR and a bacteriophage-based assay for rapid phenotypic detection of rifampin resistance in clinical isolates of Mycobacterium tuberculosis. J Clin Microbiol (1999) 1.25
In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. Antimicrob Agents Chemother (1993) 1.24
Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro. Antimicrob Agents Chemother (1988) 1.22
Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005-2008. Emerg Infect Dis (2011) 1.19
Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J Clin Microbiol (1995) 1.17
Development of a rapid method for determining the susceptibility of Mycobacterium tuberculosis to isoniazid using the Gen-Probe DNA Hybridization System. Antimicrob Agents Chemother (1989) 1.13
Direct drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter study. J Clin Microbiol (2011) 1.12
The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results. J Korean Med Sci (2007) 1.11
Two liquid medium systems, mycobacteria growth indicator tube and MB redox tube, for Mycobacterium tuberculosis isolation from sputum specimens. J Clin Microbiol (2000) 1.09
Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. J Clin Microbiol (1998) 1.09
Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis. Curr Opin Infect Dis (2008) 1.07
Comparison of three isolation systems for the culture of mycobacteria from respiratory and non-respiratory samples. J Clin Pathol (2000) 1.06
Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples. J Clin Microbiol (2008) 1.05
High-resolution melting analysis for the rapid detection of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis. PLoS One (2012) 1.01
Mycobacterium gordonae pseudoinfection associated with a contaminated antimicrobial solution. J Clin Microbiol (1990) 0.99
Molecular diversity of Mycobacterium tuberculosis isolates from patients with tuberculosis in Honduras. BMC Microbiol (2010) 0.99
Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. J Clin Microbiol (2003) 0.98
New simple decontamination method improves microscopic detection and culture of mycobacteria in clinical practice. Infect Drug Resist (2008) 0.97
Multidrug resistant tuberculosis: practical lessons for HIV units. Genitourin Med (1996) 0.95
New drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay. J Clin Microbiol (1996) 0.92
Mycobacterium tuberculosis complex drug resistance in Italy. Emerg Infect Dis (2004) 0.90
Safe determination of susceptibility of Mycobacterium tuberculosis to antimycobacterial agents by flow cytometry. J Clin Microbiol (1999) 0.90
Growth kinetics of Mycobacterium tuberculosis measured by quantitative resazurin reduction assay: a tool for fitness studies. Braz J Microbiol (2010) 0.90
Pseudoepidemic of Nocardia asteroides associated with a mycobacterial culture system. J Clin Microbiol (1992) 0.88
Anti tuberculosis drug resistance in west of iran. J Glob Infect Dis (2014) 0.88
Tuberculosis: 7. Laboratory aspects of diagnosis. CMAJ (1999) 0.83
Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J Clin Microbiol (1996) 0.83
Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2011) 0.82
Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening. Public Health Rep (2000) 0.80
Mycobacterium malmoense bacteremia in two AIDS patients. J Clin Microbiol (1996) 0.79
Increased sensitivity of the BACTEC 460 mycobacterial radiometric broth culture system does not decrease the number of respiratory specimens required for a definitive diagnosis of pulmonary tuberculosis. J Clin Microbiol (2000) 0.78
Evaluation of a commercial radiometric system for primary isolation of mycobacteria over a fifteen-year period. Eur J Clin Microbiol Infect Dis (1997) 0.78
Evaluation of the performance of nitrate reductase assay for rapid drug-susceptibility testing of mycobacterium tuberculosis in north India. J Health Popul Nutr (2011) 0.76
Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study. BMC Infect Dis (2016) 0.75
True facets of TB diagnosis in 2012: Hypes and realities. Eur J Microbiol Immunol (Bp) (2012) 0.75
Comparison of the MB/BacT and BACTEC 460 TB systems. J Clin Microbiol (1999) 0.75
Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media. Am Rev Respir Dis (1977) 11.20
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67
A selective oleic acid albumin agar medium for tubercle bacilli. J Med Microbiol (1972) 6.78
Radiometric detection of the metabolic activity of Mycobacterium tuberculosis. J Nucl Med (1975) 5.30
Rapid susceptibility testing of Mycobacterium tuberculosis by a radiometric technique. J Antimicrob Chemother (1982) 3.52
Evaluation of rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (1981) 9.67
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother (1993) 8.36
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Identification of mycobacteria from culture by using the Gen-Probe Rapid Diagnostic System for Mycobacterium avium complex and Mycobacterium tuberculosis complex. J Clin Microbiol (1988) 7.74
Comparison of a radiometric method (BACTEC) and conventional culture media for recovery of mycobacteria from smear-negative specimens. J Clin Microbiol (1983) 7.02
Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine. J Clin Microbiol (1995) 6.02
Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol (1996) 5.80
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol (1985) 5.22
Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J Clin Microbiol (1986) 5.19
Collaborative feasibility study of a biphasic system (Roche Septi-Chek AFB) for rapid detection and isolation of mycobacteria. J Clin Microbiol (1991) 4.91
Identification of clinical isolates of mycobacteria with gas-liquid chromatography alone. J Clin Microbiol (1979) 4.67
Opportunities for and challenges of computerisation. Lancet (1998) 4.39
The 7H11 medium for the cultivation of mycobacteria. Am Rev Respir Dis (1968) 4.23
Medical student selection--time for change: discussion paper. J R Soc Med (1989) 4.08
Simplified approach to identification of aerobic actinomycetes by thin-layer chromatography. Appl Microbiol (1974) 4.06
Detection of fungi in blood cultures. J Clin Microbiol (1975) 4.05
Evaluation of a lysis-centrifugation system for recovery of yeasts and filamentous fungi from blood. J Clin Microbiol (1983) 3.79
The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc (1999) 3.79
Evaluation of the modified API 20C system for identification of clinically important yeasts. J Clin Microbiol (1979) 3.77
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother (1997) 3.75
easyLINKAGE-Plus--automated linkage analyses using large-scale SNP data. Bioinformatics (2005) 3.68
Role of solid media when used in conjunction with the BACTEC system for mycobacterial isolation and identification. J Clin Microbiol (1991) 3.60
Immunological evaluation of a component isolated from Mycobacterium bovis BCG with a monoclonal antibody to M. bovis BCG. Infect Immun (1984) 3.46
Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clin Microbiol (1994) 3.46
Recovery of yeast from vented blood culture bottles. J Clin Microbiol (1975) 3.42
Untoward effects associated with practolol administration: oculomucocutaneous syndrome. Br Med J (1975) 3.33
Molecular probes for diagnosis of fungal infections. J Clin Microbiol (1995) 3.29
Rapid radiometric methods to detect and differentiate Mycobacterium tuberculosis/M. bovis from other mycobacterial species. Am Rev Respir Dis (1984) 3.25
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med (1983) 3.06
Detection of mycobacteria by radiometric and standard plate procedures. J Clin Microbiol (1983) 2.85
Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol (1983) 2.84
Evaluation of YeastIdent and Uni-Yeast-Tek yeast identification systems. J Clin Microbiol (1987) 2.74
Interlaboratory drug susceptibility testing of Mycobacterium tuberculosis by a radiometric procedure and two conventional methods. J Clin Microbiol (1985) 2.68
Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol (1993) 2.66
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii. Antimicrob Agents Chemother (1984) 2.65
Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob Agents Chemother (1981) 2.62
Effects of ibuprofen on the physiology and survival of hypothermic sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med (1999) 2.60
Pneumococcal immunisation and the healthy elderly. Lancet (1992) 2.58
A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye (Lond) (1993) 2.57
Helping clinicians to find data and avoid delays. Lancet (1998) 2.57
Rapid urea broth test for yeasts. J Clin Microbiol (1978) 2.50
Storage of stock cultures of filamentous fungi, yeasts, and some aerobic actinomycetes in sterile distilled water. Appl Microbiol (1974) 2.50
Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin Microbiol Rev (1988) 2.48
Socioeconomic status and adolescent injuries. Soc Sci Med (1997) 2.48
Evaluation of the updated Vitek yeast identification data base. J Clin Microbiol (1990) 2.45
Identification of atypical mycobacteria by thin-layer chromatography of their surface antigens. J Clin Microbiol (1978) 2.40
Mycobacteremia and the new blood culture systems. Ann Intern Med (1983) 2.39
Evaluation of a rapid radiometric differentiation test for the Mycobacterium tuberculosis complex by selective inhibition with p-nitro-alpha-acetylamino-beta-hydroxypropiophenone. J Clin Microbiol (1984) 2.39
Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy. Eye (Lond) (1994) 2.34
Comparison of four methods for determining nitrate utilization by cryptococci. J Clin Microbiol (1975) 2.29
Significance of hyperintense vessels on FLAIR MRI in acute stroke. Neurology (2000) 2.27
Recent taxonomic developments and changes in medical mycology. Annu Rev Microbiol (1980) 2.25
Nocardiosis. A review of 25 cases occurring during 24 months. Mayo Clin Proc (1975) 2.19
Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol (1985) 2.18
Emerging agents of phaeohyphomycosis: pathogenic species of Bipolaris and Exserohilum. J Clin Microbiol (1986) 2.17
Retrospective comparison of three blood culture media for the recovery of yeasts from clinical specimens. Eur J Clin Microbiol (1983) 2.15
pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother (2000) 2.10
A rationalised virological electron microscope specimen testing policy. PHLS North West Viral Gastroenteritis and Electron Microscopy Subcommittee. J Clin Pathol (1999) 2.09
Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in clinical specimens by using single-tube heminested PCR. J Clin Microbiol (1995) 2.08
Studies on Emmonsiella capsulata (Histoplasma capsulatum). II. Distribution of the two mating types in 13 endemic states of the United States. Am J Epidemiol (1974) 2.06
The seroagglutination test in the study of nontuberculous mycobacteria. Rev Infect Dis (1982) 2.01
Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J Neurosci (1996) 2.01
Evaluation of the API 20 c microtube system for the identification of clinically important yeasts. J Clin Microbiol (1976) 2.00
Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J Infect Dis (1995) 1.98
Clinical evaluation of the lysis-centrifugation blood culture system for the detection of fungemia and comparison with a conventional biphasic broth blood culture system. J Clin Microbiol (1984) 1.97
Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. Am J Psychiatry (1997) 1.94
Evaluation of a caffeic acid-ferric citrate test for rapid identification of Cryptococcus neoformans. J Clin Microbiol (1977) 1.91
Assessment of barium impregnated polyethylene spheres (BIPS) as a measure of solid-phase gastric emptying in normal dogs--comparison to scintigraphy. Vet Radiol Ultrasound (1999) 1.91
Isolation of mycobacteria from clinical specimens by use of selective 7H11 medium. Am J Clin Pathol (1976) 1.90
Immunologic diagnosis of tuberculosis: a review. Tuber Lung Dis (2000) 1.90
Isolation of skin test-active preparations from yeast-phase cells of Blastomyces dermatitidis. Infect Immun (1974) 1.90
Complete primary structure of prostatropin, a prostate epithelial cell growth factor. Biochemistry (1986) 1.89
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex. Antimicrob Agents Chemother (1982) 1.89
Lacazia loboi gen. nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol (1999) 1.86
Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun (1992) 1.86
Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay. J Clin Microbiol (1995) 1.85
Clinical comparison of BACTEC 9240 plus aerobic/F resin bottles and the isolator aerobic culture system for detection of bloodstream infections. J Clin Microbiol (1997) 1.81
Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens. Diagn Microbiol Infect Dis (1994) 1.81
Evaluation of the Baxter-MicroScan 4-hour enzyme-based yeast identification system. J Clin Microbiol (1991) 1.76
Clinical and mycological spectra of Wangiella dermatitidis infections. Mycoses (1994) 1.69
Clinical and epidemiological importance of typing of Mycobacterium avium complex isolates. J Clin Microbiol (1992) 1.69
Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol (1973) 1.68
Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections. N Engl J Med (1970) 1.67
Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J Med Vet Mycol (1996) 1.67
Design of forms for clinical trials (1). Br Med J (1979) 1.64
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med (1996) 1.64
Identification of clinical isolates of mycobacteria with gas-liquid chromatography: a 10-month follow-up study. J Clin Microbiol (1982) 1.63
Electric field-induced magnetization switching in epitaxial columnar nanostructures. Nano Lett (2005) 1.61
Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population. J Infect Dis (1996) 1.61
Multicenter evaluation of a Candida albicans peptide nucleic acid fluorescent in situ hybridization probe for characterization of yeast isolates from blood cultures. J Clin Microbiol (2005) 1.60
Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophages. Antimicrob Agents Chemother (1994) 1.60
Corrected version specificity of the latex test for cryptococcal antigen: a rapid, simple method for eliminating interference factors. J Clin Microbiol (1983) 1.59
Design of forms for clinical trials (3). Br Med J (1979) 1.59
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Antimicrob Agents Chemother (2000) 1.59
Gen-probe test should not be considered final in Mycobacterium tuberculosis identification. J Clin Microbiol (1989) 1.58
Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology (1993) 1.58
Safety and antigenicity of temperature sensitive (TS) mutant respiratory syncytial virus (RSV) in infants and children. Pediatrics (1973) 1.57
A method for separation of phosphatidylcholine, triacylglycerol, non-esterified fatty acids and cholesterol esters from plasma by solid-phase extraction. Br J Nutr (2000) 1.56